By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Live Trading NewsLive Trading NewsLive Trading News
  • Stocks
  • Forex
  • Gold
  • KNIGHTS
  • Luxury
  • Horse Racing
  • Trade Now
Search
Reading: ‘Moonshot’ Investments
Share
Live Trading NewsLive Trading News
  • Stocks
  • Forex
  • Gold
  • KNIGHTS
  • Luxury
  • Horse Racing
  • Trade Now
Search
  • Stocks
  • Forex
  • Gold
  • KNIGHTS
  • Luxury
  • Horse Racing
  • Trade Now
Follow US
© 2024 LiveTradingNews.com - All Rights Reserved.
Live Trading News > Blog > Knightsbridge Insights > ‘Moonshot’ Investments
Knightsbridge Insights

‘Moonshot’ Investments

Paul Ebeling
Last updated: September 17, 2021 4:11 am
Paul Ebeling
Share
3 Min Read
moonshot
SHARE

#Moonshot #investments #synbio

$MOON

“‘Moonshot’ is a term that Alphabet/Google began using it to describe research projects that were treated as possible businesses because the project had a shot at developing a business model and, even better, monetized. This is the1st time I have used it” — Paul Ebeling

Synthetic biology, or synbio, comprises the design and manufacture of biological systems and components that do not exist in the real world. To do this, scientists edit altered DNA before re-engineering DNA sequences from anything and putting them together into new genomes.

Interestingly, a couple of the synbio companies got their start several yrs ago as biofuel makers.

Amyris now makes synthetic elements for a variety of clean health and beauty products.

Codexis discovers, develops and sells biocatalysts, and its protein engineering platform is used by customers to discover novel biotherapeutic drug candidates.

Gevo remains as a biofuels maker and recently got a shot in the arm following an announcement that it was teaming up with Chevron to build a new plant to produce sustainable aviation fuel from corn.

Investment in synbio startups soared to $4.6-B in Q-1 of this yr, up 5X compared with Q-1 of Y 2020. At that rate, investment in synbio will rise by 200% to 400% Y-Y in Y 2021’s total investment of around $8-B.

Therapeutics claim the lion’s share of the investment because that is where the risk-reward profile is best. And the emphasis should be on the reward because the risk is not substantially different for diagnostics and similar technologies.

The company attracting the largest investment in the first quarter was ElevateBio, which raised $525-M in a Series C venture round. The 2nd-largest total went to Insitro, which raised $400-M in a Series C round.

The Direxion Moonshot Innovators ETF (NYSEArca:MOON) offers exposure to the 50 most innovative US companies at the forefront of changing our lives today, and tomorrow, by identifying the companies both pursuing innovation, and having the potential to disrupt existing technologies and/or industries. These 50 companies selected for inclusion are deemed to have the highest “early-stage composite innovation scores” and they span themes and emerging sectors such as smart transportation, clean power, and the human evolution.

Have a prosperous weekend. Keep the Faith!

You Might Also Like

InfoFi: The Latest Abomination in Crypto

Ethereum Trading Outlook

Bitcoin Trading Outlook

The 20 Great Quotes of John McAfee

Bitcoin Might Be Bumpy BUY THE DIP

TAGGED:investmentinvestmentsMoonshotsynbio

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

Subscribe our newsletter for latest news around the world. Let's stay updated!

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
By Paul Ebeling
Paul A. Ebeling, a polymath, excels, in diverse fields of knowledge Including Pattern Recognition Analysis in Equities, Commodities and Foreign Exchange, and he is the author of "The Red Roadmaster's Technical Report on the US Major Market Indices, a highly regarded, weekly financial market commentary. He is a philosopher, issuing insights on a wide range of subjects to over a million cohorts. An international audience of opinion makers, business leaders, and global organizations recognize Ebeling as an expert.   
Previous Article saGettyImages 552163367 d45e095169504769bf54a0a8a612c5f9 701x499 1 Wall Street’s Key Stock Analysts Research Reports, All Buys
Next Article f54c04 27980e22610442d0b36420ce89d8403a ‘Triple Witching’ Happens Today
Buy Bitcoin

Buy Bitcoin

Latest News

Saint Francis of Assisi in Ecstasy Caravaggio c.1595
St. Francis: The Deeds You Do Today
Catholic Featured Headline News Lifestyle Lifestyles of the RIch and Famous Living Luxury Opinion Politics Shayne Heffernan July 11, 2025
Screenshot 26 6 2025 132527
Tokenization and the Future of Financial Markets
Bitcoin Blockchain DeFI Digital Assets Economy Headline News KXCO Politics USD July 11, 2025
czi0oawj8y561
Asia’s Growth Resilience Amid U.S. Tariffs
America Asia Asia Business Featured Headline News KXCO Politics USD July 10, 2025
trump comp 835dbf
What We Know Exists in the Epstein Files
America Headline News Opinion Politics Shayne Heffernan July 8, 2025

Stay Connected

235.3kFollowersLike
69.1kFollowersFollow
11.6kFollowersPin
56.4kFollowersFollow
4.4kFollowersFollow
//

Stay informed with LiveTradingNews.com – your ultimate destination for timely and insightful updates on global markets, finance, and investment trends. Explore the latest news and analysis to empower your trading decisions.

Quick Link

  • About us
  • Advertise
  • Send us a tip!
  • Privacy Policy
  • Contact us

Top Categories

  • Knightsbridge Insights
  • Featured
  • Stocks
  • Shayne Heffernan
  • Lifestyle

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Subscribe our newsletter for latest news around the world. Let's stay updated!

Live Trading NewsLive Trading News
Follow US
© 2025 LiveTradingNews - For The Traders, By The Traders – All Right Reserved By Knightsbridge Group
Welcome Back!

Sign in to your account

Register Lost your password?